Authors: WILSON WH BATES SE FOJO A BRYANT G ZHAN Z REGIS J WITTES RE JAFFE ES STEINBERG SM HERDT J CHABNER BA

Citation: Wh. Wilson et al., CONTROLLED TRIAL OF DEXVERAPAMIL, A MODULATOR OF MULTIDRUG-RESISTANCE, IN LYMPHOMAS REFRACTORY TO EPOCH CHEMOTHERAPY, Journal of clinical oncology, 13(8), 1995, pp. 1995-2004

Authors: SAUSVILLE EA HEADLEE D STETLERSTEVENSON M JAFFE ES SOLOMON D FIGG WD HERDT J KOPP WC RAGER H STEINBERG SM GHETIE V SCHINDLER J UHR J WITTES RE VITETTA ES

Citation: Ea. Sausville et al., CONTINUOUS-INFUSION OF THE ANTI-CD22 IMMUNOTOXIN IGG-RFB4-SMPT-DGA INPATIENTS WITH B-CELL LYMPHOMA - A PHASE-I STUDY, Blood, 85(12), 1995, pp. 3457-3465

Authors: WILSON WH BERG SL BRYANT G WITTES RE BATES S FOJO A STEINBERG SM GOLDSPIEL BR HERDT J OSHAUGHNESSY J BALIS FM CHABNER BA

Citation: Wh. Wilson et al., PACLITAXEL IN DOXORUBICIN-REFRACTORY OR MITOXANTRONE-REFRACTORY BREAST-CANCER - A PHASE I II TRIAL OF 96-HOUR INFUSION/, Journal of clinical oncology, 12(8), 1994, pp. 1621-1629

Authors: WILSON WH BRYANT G BATES S FOJO A WITTES RE STEINBERG SM KOHLER DR JAFFE ES HERDT J CHESON BD CHABNER BA

Citation: Wh. Wilson et al., EPOCH CHEMOTHERAPY - TOXICITY AND EFFICACY IN RELAPSED AND REFRACTORYNON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 11(8), 1993, pp. 1573-1582